Active Shortage

APO-LAMIVUDINE-ZIDOVUDINE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-LAMIVUDINE-ZIDOVUDINE in Canada?

Yes. APO-LAMIVUDINE-ZIDOVUDINE 300MG 150MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is APO-LAMIVUDINE-ZIDOVUDINE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-LAMIVUDINE-ZIDOVUDINE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength300MG 150MG

Report last updated2026-11-05

Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02375540

Strength

300MG 150MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ZIDOVUDINE LAMIVUDINE

Tier

Unrated

Last Updated

2026-11-05

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-LAMIVUDINE-ZIDOVUDINE has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-27

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244